Proportion of the target population who received a 3rd dose of in Latin America and the Caribbean

Latin America and the Caribbean: Proportion of the target population who received a 3rd dose of was 76.0% in 2024. ▲ Rising

Latest (2024)
76.0%
Change on year
up 4.1%
Rank
17th
of 37 groups
All-time high
82.0%
in 2015
All-time low
3.0%
in 2008
Years of data
17
2008–2024

Proportion of the target population who received a 3rd dose of in Latin America and the Caribbean, 2008–2024

0204060802008201620242008: 32009: 112010: 352011: 602012: 712013: 762014: 802015: 822016: 792017: 782018: 782019: 772020: 742021: 712022: 732023: 732024: 76

Source: United Nations Statistics Division, SDG Global Database.

Analysis

In 2024, proportion of the target population who received a 3rd dose of in Latin America and the Caribbean stood at 76.0%.

The figure is up 4.1% on the previous year and down 5.0% over ten years.

Over the whole period, proportion of the target population who received a 3rd dose of in Latin America and the Caribbean peaked at 82.0% in 2015 and was at its lowest, 3.0%, in 2008.

That places Latin America and the Caribbean 17th out of 37 groups with data for 2024, putting it in the middle of the range.

The long-run direction has been consistently rising across the 17 years of available data.

Proportion of the target population who received a 3rd dose of in Latin America and the Caribbean, year by year

Annual values for Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%) in Latin America and the Caribbean, 2008 to 2024.
Year Value Change
2008 3.0%
2009 11.0% +266.7%
2010 35.0% +218.2%
2011 60.0% +71.4%
2012 71.0% +18.3%
2013 76.0% +7.0%
2014 80.0% +5.3%
2015 82.0% +2.5%
2016 79.0% -3.7%
2017 78.0% -1.3%
2018 78.0% +0.0%
2019 77.0% -1.3%
2020 74.0% -3.9%
2021 71.0% -4.1%
2022 73.0% +2.8%
2023 73.0% +0.0%
2024 76.0% +4.1%

Biggest year-on-year movements

Years where Proportion of the target population who received a 3rd dose of in Latin America and the Caribbean changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2009 +266.7% 3.0% 11.0%
2010 +218.2% 11.0% 35.0%
2011 +71.4% 35.0% 60.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 7.0% 3.0% 11.0% 2
2010s 71.6% 35.0% 82.0% 10
2020s 73.4% 71.0% 76.0% 5

Countries ranked near Latin America and the Caribbean

  1. 16 Andorra 96.0% compare
  2. 16 Denmark 96.0% compare
  3. 16 El Salvador 96.0% compare
  4. 16 France 96.0% compare
  5. 16 Ghana 96.0% compare
  6. 16 Kuwait 96.0% compare
  7. 16 Mongolia 96.0% compare
  8. 16 Nepal 96.0% compare
  9. 16 Qatar 96.0% compare
  10. 16 Saudi Arabia 96.0% compare
  11. 16 Slovakia 96.0% compare
  12. 16 Uruguay 96.0% compare

See the full ranking of 194 places →

More infrastructure data for Latin America and the Caribbean

All data for Latin America and the Caribbean →

Frequently asked questions

What is proportion of the target population who received a 3rd dose of in Latin America and the Caribbean?
Proportion of the target population who received a 3rd dose of in Latin America and the Caribbean was 76.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest proportion of the target population who received a 3rd dose of recorded in Latin America and the Caribbean?
The highest recorded value was 82.0% in 2015.
What is the lowest proportion of the target population who received a 3rd dose of recorded in Latin America and the Caribbean?
The lowest recorded value was 3.0% in 2008.
How does Latin America and the Caribbean rank for proportion of the target population who received a 3rd dose of?
Latin America and the Caribbean ranks 17th out of 37 groups with data for 2024.
Is proportion of the target population who received a 3rd dose of rising or falling in Latin America and the Caribbean?
Over the last ten years it is down 5.0%. The long-run trend across the full record is rising.
Where does this Latin America and the Caribbean data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 17 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Proportion of the target population who received a 3rd dose of in Latin America and the Caribbean. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 13 September 2026, from https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-a-3rd-dose-of-pneumococcal-conjugate/latin-america-and-the-caribbean/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-a-3rd-dose-of-pneumococcal-conjugate/latin-america-and-the-caribbean/">Proportion of the target population who received a 3rd dose of in Latin America and the Caribbean</a> — Statizoid

About this data

Indicator
Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
194 places, 2,558 data points, 2008–2024
Last refreshed